Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919414 | Radiotherapy and Oncology | 2011 | 7 Pages |
Abstract
Autocrine activation of EGFR leading to EMT is associated with a metastatic phenotype and reduced sensitivity of SCCHN cells to single-modality treatment with cetuximab or irradiation. The potential of Snail1 as biomarker for selection of patients who will mostly benefit from a combination of cetuximab and radiotherapy has to be evaluated in future clinical studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carmen Holz, Franziska Niehr, Mariya Boyko, Tsvetana Hristozova, Luitpold Distel, Volker Budach, Ingeborg Tinhofer,